Fig. 1From: Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetesZ-score of skin autofluorescence in relationship to presence of type 2 diabetes and cardiovascular disease. Data are presented as mean ± SEM. For comparison, age-corrected SAF scores are compared with Lifelines participants without diabetes (‘No T2D’). * denotes p < 0.001 versus people with New T2D; $ p = 0.009 vs New T2D; # p < 0.001 vs Known T2D. All are p < 0.001 vs No T2DBack to article page